News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.

Pembrolizumab Active in Advanced Gastric Cancer

The anti–PD-1 monoclonal antibody, pembrolizumab (MK-3475), demonstrated promising antitumor activity in advanced gastric cancer, results from the KEYNOTE-012 study presented at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting have found.